Lumantam, Jonathan C.
HRN: 28 36 18 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2026
CEFTRIAXONE 1G (VIAL)
01/02/2026
01/09/2026
IV
2G
OD
Acute Appendicitis
Checking Final Appropriateness
01/02/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/02/2026
01/09/2026
IV
2G
OD
Acute Appendicitis
Checking Final Appropriateness
01/02/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/02/2026
01/09/2026
IV
500MG
Q8H
Acute Appendicitis
Checking Final Appropriateness